{"article_title": "Obesity & diabetes take center stage at Cleveland Clinic Medical Innovations Summit", "article_keywords": ["center", "medical", "healthcare", "companies", "innovations", "clinic", "summit", "health", "cleveland", "including", "obesity", "stage", "panel", "diabetes"], "article_url": "http://medcitynews.com/2013/10/cleveland-clinic-puts-obesity-diabetes-center-stage-2013-medical-innovations-summit/", "article_text": "This year\u2019s Cleveland Clinic Medical Innovations Summit will pick up right where last year\u2019s left off.\n\nLast year, the Clinic put at the top of its annual Top 10 Medical Innovations list bariatric surgery for treatment of diabetes as the advancement most likely to change medicine over the next year. So it\u2019s no surprise that this year\u2019s summit, which runs Monday through Wednesday, will focus on healthcare industry trends around obesity, diabetes and the metabolic crisis.\n\nDr. Philip Schauer, the director of the Bariatric and Metabolic Institute at the Clinic, was the lead researcher on a key study published in the New England Journal of Medicine last year on bariatric surgery and type 2 diabetes. He\u2019ll likely be a prominent voice at this year\u2019s summit, in addition to the health system\u2019s media darling CEO Toby Cosgrove\n\nNaturally, we can expect some showing off of the Clinic\u2019s doctors, research and innovation efforts. But it\u2019s also bringing in a well-rounded set of speakers and panelists including medical device and pharmaceutical industry executives, investors, startups, analysts and clinicians. One particularly interesting panel on the state of healthcare innovations includes the CEOs of Cardinal Health, AstraZeneca, WellPoint and the Clinic as well as partners from Foundation Medical Partners and GE Ventures.\n\nAdvertisement\n\nTwo features added this year also bring startup companies into the mix in a big way. The first is the New Ventures Healthcare Challenge, presented in collaboration with StartUp Health. Eleven emerging companies including AdhereTech, Force Therapeutics and QMedic will present to a rather intimidating panel of judges including Esther Dyson and the clinic\u2019s CIO, Dr. Martin Harris.\n\nThere\u2019s also a showcase of wellness and diabetes-focused startups on Tuesday that will be getting feedback from a panel of investors and executives.\n\nThe summit will close out Wednesday with an update on the ongoing IBM Watson project at the Cleveland Clinic Lerner College of Medicine.\n\nIt\u2019s worth pointing out, too, that everything will be happening at Cleveland\u2019s new convention center, which is attached to the medical mart-turned-Global Center for Health Innovation that opened this week. The Clinic, along with GE Healthcare, HIMSS and several other notable companies have all taken out space there.\n\nCheck back next week for live coverage from the event. I\u2019ll also be tweeting (@deannajour231) using the hashtag #MIS2013 if you\u2019d like to follow along.", "article_metadata": {"description": "This year\u2019s Cleveland Clinic Medical Innovations Summit will pick up right where last year\u2019s left off. Last year, the Clinic put at the top of its annual Top 10 Medical Innovations list bariatric surgery for treatment of diabetes as the advancement most likely to change medicine over the next year. So it\u2019s no surprise that this year\u2019s summit, which runs Monday through Wednesday, will focus on healthcare industry trends around obesity, diabetes and the metabolic crisis. Dr. Philip Schauer, the director of the Bariatric and Metabolic Institute at the Clinic, was the lead researcher on a key study published in the New England Journal of Medicine last year on bariatric surgery and type 2 diabetes. He\u2019ll likely be a prominent voice at this year\u2019s summit, in addition to the health system\u2019s media darling CEO Toby Cosgrove Naturally, we can expect some showing off of the Clinic\u2019s doctors, research and innovation efforts. \u00a0But it\u2019s also bringing in a well-rounded set of speakers and panelists including medical device and pharmaceutical industry executives, investors, startups, analysts and clinicians. One particularly interesting panel on the state of healthcare innovations includes the CEOs of Cardinal Health, AstraZeneca, WellPoint and the Clinic as well as partners from Foundation Medical Partners and GE Ventures. Two features added this year also bring startup companies into the mix in a big way. The first is the New Ventures Healthcare Challenge, presented in collaboration with StartUp Health. Eleven emerging companies including AdhereTech, Force Therapeutics and QMedic will present to a rather intimidating panel of judges including Esther Dyson and the clinic\u2019s CIO, Dr. Martin Harris. There\u2019s also a showcase of wellness and diabetes-focused startups on Tuesday that will be getting feedback from a panel of investors and executives. The summit will close out Wednesday with an update on the ongoing IBM Watson project at the Cleveland Clinic Lerner College of Medicine. It\u2019s worth pointing out, too, that everything will be happening at Cleveland\u2019s new convention center, which is attached to the medical mart-turned-Global Center for Health Innovation that opened this week. The Clinic, along with GE Healthcare, HIMSS and several other notable companies have all taken out space there. Check back next week for live coverage from the event. I\u2019ll also be tweeting (@deannajour231) using the hashtag #MIS2013 if you\u2019d like to follow along.", "generator": "WordPress 4.5.2", "og": {"site_name": "MedCity News", "description": "This year\u2019s Cleveland Clinic Medical Innovations Summit will pick up right where last year\u2019s left off. Last year, the Clinic put at the top of its annual Top 10 Medical Innovations list bariatric surgery for treatment of diabetes as the advancement most likely to change medicine over the next year. So it\u2019s no surprise that this year\u2019s summit, which runs Monday through Wednesday, will focus on healthcare industry trends around obesity, diabetes and the metabolic crisis. Dr. Philip Schauer, the director of the Bariatric and Metabolic Institute at the Clinic, was the lead researcher on a key study published in the New England Journal of Medicine last year on bariatric surgery and type 2 diabetes. He\u2019ll likely be a prominent voice at this year\u2019s summit, in addition to the health system\u2019s media darling CEO Toby Cosgrove Naturally, we can expect some showing off of the Clinic\u2019s doctors, research and innovation efforts. \u00a0But it\u2019s also bringing in a well-rounded set of speakers and panelists including medical device and pharmaceutical industry executives, investors, startups, analysts and clinicians. One particularly interesting panel on the state of healthcare innovations includes the CEOs of Cardinal Health, AstraZeneca, WellPoint and the Clinic as well as partners from Foundation Medical Partners and GE Ventures. Two features added this year also bring startup companies into the mix in a big way. The first is the New Ventures Healthcare Challenge, presented in collaboration with StartUp Health. Eleven emerging companies including AdhereTech, Force Therapeutics and QMedic will present to a rather intimidating panel of judges including Esther Dyson and the clinic\u2019s CIO, Dr. Martin Harris. There\u2019s also a showcase of wellness and diabetes-focused startups on Tuesday that will be getting feedback from a panel of investors and executives. The summit will close out Wednesday with an update on the ongoing IBM Watson project at the Cleveland Clinic Lerner College of Medicine. It\u2019s worth pointing out, too, that everything will be happening at Cleveland\u2019s new convention center, which is attached to the medical mart-turned-Global Center for Health Innovation that opened this week. The Clinic, along with GE Healthcare, HIMSS and several other notable companies have all taken out space there. Check back next week for live coverage from the event. I\u2019ll also be tweeting (@deannajour231) using the hashtag #MIS2013 if you\u2019d like to follow along.", "title": "Obesity & diabetes take center stage at Cleveland Clinic Medical Innovations Summit", "locale": "en_US", "image": "http://medcitynews.com/wp-content/uploads/childhood-obesity.jpg", "updated_time": "2015-04-08T16:39:45-04:00", "url": "http://medcitynews.com/2013/10/cleveland-clinic-puts-obesity-diabetes-center-stage-2013-medical-innovations-summit/", "type": "article"}, "twitter": {"image": "http://medcitynews.com/wp-content/uploads/childhood-obesity.jpg", "description": "This year\u2019s Cleveland Clinic Medical Innovations Summit will pick up right where last year\u2019s left off. Last year, the Clinic put at the top of its annual Top 10 Medical Innovations list bariatric surgery for treatment of diabetes as the advancement most likely to change medicine over the next year. So it\u2019s no surprise that this year\u2019s summit, which runs Monday through Wednesday, will focus on healthcare industry trends around obesity, diabetes and the metabolic crisis. Dr. Philip Schauer, the director of the Bariatric and Metabolic Institute at the Clinic, was the lead researcher on a key study published in the New England Journal of Medicine last year on bariatric surgery and type 2 diabetes. He\u2019ll likely be a prominent voice at this year\u2019s summit, in addition to the health system\u2019s media darling CEO Toby Cosgrove Naturally, we can expect some showing off of the Clinic\u2019s doctors, research and innovation efforts. \u00a0But it\u2019s also bringing in a well-rounded set of speakers and panelists including medical device and pharmaceutical industry executives, investors, startups, analysts and clinicians. One particularly interesting panel on the state of healthcare innovations includes the CEOs of Cardinal Health, AstraZeneca, WellPoint and the Clinic as well as partners from Foundation Medical Partners and GE Ventures. Two features added this year also bring startup companies into the mix in a big way. The first is the New Ventures Healthcare Challenge, presented in collaboration with StartUp Health. Eleven emerging companies including AdhereTech, Force Therapeutics and QMedic will present to a rather intimidating panel of judges including Esther Dyson and the clinic\u2019s CIO, Dr. Martin Harris. There\u2019s also a showcase of wellness and diabetes-focused startups on Tuesday that will be getting feedback from a panel of investors and executives. The summit will close out Wednesday with an update on the ongoing IBM Watson project at the Cleveland Clinic Lerner College of Medicine. It\u2019s worth pointing out, too, that everything will be happening at Cleveland\u2019s new convention center, which is attached to the medical mart-turned-Global Center for Health Innovation that opened this week. The Clinic, along with GE Healthcare, HIMSS and several other notable companies have all taken out space there. Check back next week for live coverage from the event. I\u2019ll also be tweeting (@deannajour231) using the hashtag #MIS2013 if you\u2019d like to follow along.", "card": "summary", "title": "Obesity & diabetes take center stage at Cleveland Clinic Medical Innovations Summit - MedCity News"}, "fb": {"app_id": 148725768475669}, "google-site-verification": "xudQg7nxVR9ifmMTY4Tf-0wVtX9b6rWLQd0utCweGOc", "keywords": "weight loss, obesity, overweight,diabetes,massachusetts,medical devices,obesity,startups,healthcare innovation, medcity news,medcity news,san francisco, startups, life sciences,accelerator,rock health,startup advice,startup funding,patient monitoring system, motion sensors ,dc,healthcare it,washington,foodborne pathogens, diagnostics company, diagnostic platforms,minimally invasive surgery, laser surgery,cambridge,dealflow,hospitals,wellpoint, healthways, health and wellness, employee wellness programs,investing,wellness,medtronic, shanghai innovation center, china, r&d,china,mdt,minneapolis,minnesota,publics,twin cities,ulcerative colitis, abbott labs, humira,abbott labs,doctors,pharmaceuticals,skin disorders, pharmaceuticals, md anderson cancer center,cancer,texas,renal denervation, st. jude medical,st. jude medical,stj,emr, ehr, electronic health records, electronic medical records, certified emr,certified emr,ehr,electronic health records,electronic medical records,advanced cellular technology,amyotrophic lateral sclerosis,embryonic stem cells,geron corporation,lou gehrig\\'s disease,macular degeneration,regenerative medicine,spinal cord damage,value-based healthcare system, obamacare, fee-for-service model,california,cleveland,health insurance,insurance,ohio,pennsylvania,politics,cancer treatment options library, aetna, aet, healthcare it,aet,aetna,health it,phi,philadelphia,Cleveland, Cleveland Clinic, Diabetes, HIMSS, hospitals, medical devices, obesity, Ohio, pharmaceuticals, , MedCity News", "article": {"section": "Hospitals", "tag": "pharmaceuticals", "published_time": "2013-10-11T10:19:09-04:00", "modified_time": "2015-04-08T16:39:45-04:00"}, "viewport": "width=device-width,initial-scale=1.0,width=device-width,user-scalable=no,minimum-scale=1.0,maximum-scale=1.0"}, "article_summary": "This year\u2019s Cleveland Clinic Medical Innovations Summit will pick up right where last year\u2019s left off.\nBut it\u2019s also bringing in a well-rounded set of speakers and panelists including medical device and pharmaceutical industry executives, investors, startups, analysts and clinicians.\nLast year, the Clinic put at the top of its annual Top 10 Medical Innovations list bariatric surgery for treatment of diabetes as the advancement most likely to change medicine over the next year.\nSo it\u2019s no surprise that this year\u2019s summit, which runs Monday through Wednesday, will focus on healthcare industry trends around obesity, diabetes and the metabolic crisis.\nThe summit will close out Wednesday with an update on the ongoing IBM Watson project at the Cleveland Clinic Lerner College of Medicine."}